{"id":4353,"date":"2024-10-18T12:42:47","date_gmt":"2024-10-18T09:42:47","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4353"},"modified":"2026-10-30T13:29:43","modified_gmt":"2026-10-30T11:29:43","slug":"iasis-pharma-participation-at-the-7th-panhellenic-conference-of-s-s-d-a-d","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-at-the-7th-panhellenic-conference-of-s-s-d-a-d\/","title":{"rendered":"IASIS PHARMA PARTICIPATION at the 7th PANHELLENIC CONFERENCE OF S.S.D.A.D."},"content":{"rendered":"<p><strong>09\/12-15\/2024,<\/strong><\/p>\n<p><strong>Portaria Hotel \/ Pilion<\/strong><\/p>\n<p>During 09\/12-15\/2024, at Portaria Hotel \/ Pilion, the <strong>Society for the Study of Dermatovenereologic <\/strong>and<strong>\u00a0Allergic Diseases<\/strong>\u00a0(S.S.D.A.D.) organized the <strong>7th Panhellenic Conference<\/strong>\u00a0\u201cDermatological diseases: Past, present and future\u201d.<\/p>\n<p>Greek Dermatologists attended the congress and visited\u00a0<strong><b>IASIS PHARMA<\/b><\/strong>\u00a0exhibition stand to get informed of 3 important IASIS Dermatological products:<\/p>\n<ul>\n<li><strong><b>Isotroin<sup>\u00ae<\/sup><\/b><\/strong>\/ Isotretinoin, (at the <strong><b>new &amp; unique<\/b><\/strong>\u00a0<strong><b>30mg<\/b><\/strong>\u00a0dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. <strong>Isotroin<b><sup>\u00ae<\/sup><\/b><\/strong><strong>\u00a030mg<\/strong>\u00a0\u00a0is added to the range of the other Isotroin<strong><b><sup>\u00ae<\/sup><\/b><\/strong> strengths \u00a0(10mg, 20mg &amp; 40mg).<\/li>\n<\/ul>\n<ul>\n<li><strong><b>Combi<sup>\u00ae<\/sup><\/b><\/strong>, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.<\/li>\n<\/ul>\n<ul>\n<li><strong><b>Modiwart<sup>\u00ae<\/sup><\/b><\/strong>\/\u0399miquimod (12,5mg\/sachet), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignleft size-full wp-image-4349\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1.png\" alt=\"%cf%80%ce%b7%ce%bb%ce%b9%ce%bf-copy-1\" width=\"450\" height=\"469\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1-120x125.png 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1-200x208.png 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1-288x300.png 288w, https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1-400x417.png 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2024\/10\/\u03c0\u03b7\u03bb\u03b9\u03bf-copy-1-1.png 450w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>09\/12-15\/2024, Portaria Hotel \/ Pilion During 09\/12-15\/2024, at Portaria Hotel \/ Pilion, the Society for the Study of Dermatovenereologic and\u00a0Allergic Diseases\u00a0(S.S.D.A.D.) organized the 7th Panhellenic Conference\u00a0\u201cDermatological diseases: Past, present and future\u201d. Greek Dermatologists attended the congress and visited\u00a0IASIS PHARMA\u00a0exhibition stand to get informed of 3 important IASIS Dermatological products: Isotroin\u00ae\/ Isotretinoin, (at the new &amp;  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4353","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-18d","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4353"}],"version-history":[{"count":1,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4353\/revisions"}],"predecessor-version":[{"id":4354,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4353\/revisions\/4354"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}